Cisplatin resistance: preclinical findings and clinical implications.
about
The Tumorigenic Roles of the Cellular REDOX Regulatory SystemsSystems biology of cisplatin resistance: past, present and futureNanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein traffickingA common polymorphism in the 5' UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy.Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLCInhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell linesBiodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenograftsVirtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interactionAkt1 enhances CA916798 expression through mTOR pathwayEndoplasmic reticulum stress is involved in the response of human laryngeal carcinoma cells to Carboplatin but is absent in Carboplatin-resistant cellsDeterminants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijackingThe Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder CancerSafety and efficacy of quadrapeutics versus chemoradiation in head and neck carcinoma xenograft model.Synthetic and natural antioxidants attenuate cisplatin-induced vomitingp53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells.Metabolic interrogation as a tool to optimize chemotherapeutic regimens.A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.Synergistic therapeutic effect of cisplatin and phosphatidylinositol 3-kinase (PI3K) inhibitors in cancer growth and metastasis of Brca1 mutant tumors.RAD52 variants predict platinum resistance and prognosis of cervical cancer.Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cells.Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.Expression of DNA translesion synthesis polymerase η in head and neck squamous cell cancer predicts resistance to gemcitabine and cisplatin-based chemotherapy.E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin.Platinum resistance in breast and ovarian cancer cell linesDNA repair mechanisms in cancer development and therapyInhibition of autophagy using 3-methyladenine increases cisplatin-induced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells.Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells.DNA polymerase ζ is a major determinant of resistance to platinum-based chemotherapeutic agents.Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo.Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer.Fluorescence-tagged metallothionein with CdTe quantum dots analyzed by the chip-CE technique.Polymeric Micelle-Mediated Delivery of DNA-Targeting Organometallic Complexes for Resistant Ovarian Cancer Treatment.Independent transcriptional reprogramming and apoptosis induction by cisplatin.Synthesis, aqueous reactivity, and biological evaluation of carboxylic acid ester-functionalized platinum-acridine hybrid anticancer agents.Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death.Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.Calcium efflux from the endoplasmic reticulum regulates cisplatin-induced apoptosis in human cervical cancer HeLa cells.
P2860
Q26774894-94AB903B-08CD-4E81-8126-A188348FC333Q26863585-6FBC6B6C-8238-4860-A446-B326E356E8E5Q27011482-3F591F4A-8880-400D-9DDD-A145DD32E2BDQ27853206-61F83C07-4BF1-4841-9E4B-7CAA0A966E08Q28478252-978772B3-76E2-4E84-B751-E03EDF3F5C40Q28481551-4BEE51FC-DA86-4972-9AD1-799B0D82FD7AQ28482418-F1CC61E7-B482-4F84-B75D-2D54DB0EAFF8Q28484387-E6B9A645-9A1B-4483-99C5-07A742B668D0Q28487802-B0B71752-F71B-4944-B5DF-EB6FABF2A5C9Q28533746-C027A562-7440-477C-9444-FAE78567AFEAQ28534972-E89A09D7-C555-43EA-BB85-37879C359175Q28552489-1ED30809-B498-41FE-9C68-9F4BB2EB1324Q30390899-3974F683-2989-4CB0-95F4-6E9C3AF66C23Q30834914-43C33198-561C-49E1-9958-B37C8E6FA7F7Q31008408-9E39FA85-E612-43F3-A606-88A68DD74E0CQ32179390-A1DF2A26-2AC8-4F8C-8006-EC19F12F7585Q33566853-27EACC9B-5F9E-413F-88E3-A937A4FEB204Q34089593-2EC72861-E077-4DD5-8C01-75B3DAB7BE17Q34107207-1552B84F-1FAC-492A-BEEE-D9FD3A623412Q34500320-B301EB89-4EA0-4729-B1F8-602412A7B2CFQ34677497-45394248-236A-4EAF-A002-6305E8E928F1Q34742904-28E8B91D-F121-471A-A713-F4B62B0DE425Q34886445-5892C1E8-E60D-4746-8C94-4D6544693D69Q35078304-C578B874-C404-424C-BE94-5D4F4477C9BDQ35135920-50D83946-CE52-4591-886C-6CA4DD2FB59AQ35397906-EF7954D2-0378-4A0E-AEEF-0318FA3C4753Q35531287-190778F2-7A04-40B3-A2E6-2E7B9E3150ABQ35728790-769C04D0-3F81-48EC-823F-17BC21ACE05DQ35767493-B7084BBE-5FCE-45C2-9574-317E16863547Q35996723-EF510513-F43C-4518-AF35-8B554ED877EDQ36057163-FC5CE91C-CBAF-4AE7-B34C-68642AD5C07AQ36085960-EB9B0B6F-32D8-4FAD-8189-DAF7D45C72A1Q36220811-E53EC7C4-7351-49AA-A9D3-5C63C670937FQ36253687-E52C8FB5-C941-4706-9AF5-C5D311EA46BEQ36304190-ED5BF97B-24F3-4E70-B1A2-7F1127BDDF33Q36340171-62987FC9-5FE4-4123-BC33-8FC6804C6616Q36557507-9B02F374-24A4-411C-8DC2-9128E4488D02Q36557513-E6794036-DAF7-4859-AAA4-D636E46FB3ECQ36654372-27B9BA78-25F8-4676-A4DA-DB717AC8C332Q36741804-B38E7EF1-6927-4EE5-89A5-787944DC0610
P2860
Cisplatin resistance: preclinical findings and clinical implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cisplatin resistance: preclinical findings and clinical implications.
@en
Cisplatin resistance: preclinical findings and clinical implications.
@nl
type
label
Cisplatin resistance: preclinical findings and clinical implications.
@en
Cisplatin resistance: preclinical findings and clinical implications.
@nl
prefLabel
Cisplatin resistance: preclinical findings and clinical implications.
@en
Cisplatin resistance: preclinical findings and clinical implications.
@nl
P2093
P1476
Cisplatin resistance: preclinical findings and clinical implications.
@en
P2093
Beate Köberle
Bernd Kaina
Maja T Tomicic
Svetlana Usanova
P304
P356
10.1016/J.BBCAN.2010.07.004
P407
P577
2010-07-17T00:00:00Z